80 related articles for article (PubMed ID: 8908507)
1. A novel packaging system for the generation of helper-free oncolytic MVM vector stocks.
Brandenburger A; Russell S
Gene Ther; 1996 Oct; 3(10):927-31. PubMed ID: 8908507
[TBL] [Abstract][Full Text] [Related]
2. Construction and production of oncotropic vectors, derived from MVM(p), that share reduced sequence homology with helper plasmids.
Clément N; Velu T; Brandenburger A
Cancer Gene Ther; 2002 Sep; 9(9):762-70. PubMed ID: 12189526
[TBL] [Abstract][Full Text] [Related]
3. A novel MVMp-based vector system specifically designed to reduce the risk of replication-competent virus generation by homologous recombination.
Dupont F; Karim A; Dumon JC; Mine N; Avalosse B
Gene Ther; 2001 Jun; 8(12):921-9. PubMed ID: 11426332
[TBL] [Abstract][Full Text] [Related]
4. Cloning and sequencing of defective particles derived from the autonomous parvovirus minute virus of mice for the construction of vectors with minimal cis-acting sequences.
Clément N; Avalosse B; El Bakkouri K; Velu T; Brandenburger A
J Virol; 2001 Feb; 75(3):1284-93. PubMed ID: 11152501
[TBL] [Abstract][Full Text] [Related]
5. In vivo anti-tumour activity of recombinant MVM parvoviral vectors carrying the human interleukin-2 cDNA.
El Bakkouri K; Servais C; Clément N; Cheong SC; Franssen JD; Velu T; Brandenburger A
J Gene Med; 2005 Feb; 7(2):189-97. PubMed ID: 15515141
[TBL] [Abstract][Full Text] [Related]
6. Autonomous parvovirus vectors: preventing the generation of wild-type or replication-competent virus.
Brandenburger A; Velu T
J Gene Med; 2004 Feb; 6 Suppl 1():S203-11. PubMed ID: 14978763
[TBL] [Abstract][Full Text] [Related]
7. Influence of sequence and size of DNA on packaging efficiency of parvovirus MVM-based vectors.
Brandenburger A; Coessens E; El Bakkouri K; Velu T
Hum Gene Ther; 1999 May; 10(7):1229-38. PubMed ID: 10340554
[TBL] [Abstract][Full Text] [Related]
8. Recombination within the nonstructural genes of the parvovirus minute virus of mice (MVM) generates functional levels of wild-type NS1, which can be detected in the absence of selective pressure following transfection of nonreplicating plasmids.
Pearson JL; Pintel DJ
Virology; 2000 Mar; 269(1):128-36. PubMed ID: 10725205
[TBL] [Abstract][Full Text] [Related]
9. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome.
Saeki Y; Fraefel C; Ichikawa T; Breakefield XO; Chiocca EA
Mol Ther; 2001 Apr; 3(4):591-601. PubMed ID: 11319922
[TBL] [Abstract][Full Text] [Related]
10. Genetic design of an optimized packaging cell line for gene vectors transducing human B cells.
Hettich E; Janz A; Zeidler R; Pich D; Hellebrand E; Weissflog B; Moosmann A; Hammerschmidt W
Gene Ther; 2006 May; 13(10):844-56. PubMed ID: 16421600
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
Zhang J; Frolov I; Russell SJ
J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589
[TBL] [Abstract][Full Text] [Related]
12. Generation of replication-defective helper-free vectors based on simian immunodeficiency virus.
Kim SS; Kothari N; You XJ; Robinson WE; Schnell T; Uberla K; Fan H
Virology; 2001 Mar; 282(1):154-67. PubMed ID: 11259198
[TBL] [Abstract][Full Text] [Related]
13. Production of lentiviral vectors by transient expression of minimal packaging genes from recombinant adenoviruses.
Kuate S; Stefanou D; Hoffmann D; Wildner O; Uberla K
J Gene Med; 2004 Nov; 6(11):1197-205. PubMed ID: 15459964
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of a minimal inducible packaging cell line for simian immunodeficiency virus-based lentiviral vectors.
Kuate S; Wagner R; Uberla K
J Gene Med; 2002; 4(4):347-55. PubMed ID: 12124977
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal integration and homologous gene targeting by replication-incompetent vectors based on the autonomous parvovirus minute virus of mice.
Hendrie PC; Hirata RK; Russell DW
J Virol; 2003 Dec; 77(24):13136-45. PubMed ID: 14645570
[TBL] [Abstract][Full Text] [Related]
16. Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors.
Sena-Esteves M; Hampl JA; Camp SM; Breakefield XO
J Gene Med; 2002; 4(3):229-39. PubMed ID: 12112640
[TBL] [Abstract][Full Text] [Related]
17. Gene transfer system derived from the caprine arthritis-encephalitis lentivirus.
Mselli-Lakhal L; Guiguen F; Greenland T; Mornex JF; Chebloune Y
J Virol Methods; 2006 Sep; 136(1-2):177-84. PubMed ID: 16797087
[TBL] [Abstract][Full Text] [Related]
18. Parvoviral vectors for the gene therapy of cancer.
Shaughnessy E; Lu D; Chatterjee S; Wong KK
Semin Oncol; 1996 Feb; 23(1):159-71. PubMed ID: 8607026
[TBL] [Abstract][Full Text] [Related]
19. Generation of a flexible cell line with regulatable, high-level expression of HIV Gag/Pol particles capable of packaging HIV-derived vectors.
Sparacio S; Pfeiffer T; Schaal H; Bosch V
Mol Ther; 2001 Apr; 3(4):602-12. PubMed ID: 11319923
[TBL] [Abstract][Full Text] [Related]
20. Encapsidation of a recombinant LuIII parvovirus genome by H1 virus and the fibrotropic or lymphotropic strains of minute virus of mice.
Maxwell IH; Long CJ; Carlson JO; Rhode SL; Maxwell F
J Gen Virol; 1993 Jun; 74 ( Pt 6)():1175-9. PubMed ID: 8509766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
